Harlan S. Robins, Chief Scientific Officer of Adaptive Biotechnologies Corporation, has reported a disposal of common shares of the company. The full filing can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780851-26-000001), on January 08, 2026, and is solely responsible for the information contained therein.